Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CASP5 |
| Upstream (Parents) |
|---|
| (<<) CASP1 → CASP5 |
| (<<) CASP4 → CASP5 |
| (<<) CD274 → CASP5 |
| (<<) ELF2 → CASP5 |
| (<<) HLA-A → CASP5 |
| (<<) IRF1 → CASP5 |
| (<<) MOBKL2C → CASP5 |
| (<<) NFKBIE → CASP5 |
| (<<) RAP1A → CASP5 |
| (<<) RCBTB1 → CASP5 |
| (<<) SERPINB1 → CASP5 |
| (<<) ZBED2 → CASP5 |
| Downstream (Children) |
|---|
| CASP5 → ATP2B4 (>>) |
| CASP5 → CKB (>>) |
| CASP5 → CXADR (>>) |
| CASP5 → ERBB3 (>>) |
| CASP5 → KCNJ2 (>>) |
| CASP5 → ME1 (>>) |
| CASP5 → MTHFD2 (>>) |
| CASP5 → PHOX2A (>>) |
| CASP5 → PIK3R3 (>>) |
| CASP5 → SMAD1 (>>) |
| CASP5 → SMAD3 (>>) |
| CASP5 → TYRO3 (>>) |
| CASP5 → UBE2D1 (>>) |
| CASP5 → VPS28 (>>) |
